Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997025034 - USE OF THE L-ENANTIOMER OF CENTCHROMAN FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF BREAST CANCER

Publication Number WO/1997/025034
Publication Date 17.07.1997
International Application No. PCT/DK1997/000007
International Filing Date 09.01.1997
Chapter 2 Demand Filed 30.07.1997
IPC
A61K 31/4025 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4025not condensed and containing further heterocyclic rings, e.g. cromakalim
CPC
A61K 31/4025
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4025not condensed and containing further heterocyclic rings, e.g. cromakalim
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • NOVO NORDISK A/S [DK]/[DK]
Inventors
  • SHALMI, Michael
  • KAMBOJ, Ved, Prakash
  • ASTHANA, Omkar, Prasad
  • RAY, Suprabhat
Agents
  • NOVO NORDISK A/S
Priority Data
0776/9611.07.1996DK
60/010,00011.01.1996US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF THE L-ENANTIOMER OF CENTCHROMAN FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF BREAST CANCER
(FR) UTILISATION DE L'ENANTIOMERE-L DE CENTCHROMANNE DANS LA FABRICATION D'UNE COMPOSITION PHARMACEUTIQUE SERVANT AU TRAITEMENT OU A LA PROPHYLAXIE DU CANCER DU SEIN
Abstract
(EN)
The present invention provides a novel use of the l-enantiomer of centchroman or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer.
(FR)
Cette invention se rapporte à une nouvelle utilisation de l'énantiomère-l de centchromanne ou d'un sel pharmaceutiquement acceptable de celui-ci, combiné à un excipient pharmaceutiquement acceptable, dans la fabrication d'une composition pharmaceutique servant au traitement ou à la prophylaxie du cancer du sein.
Latest bibliographic data on file with the International Bureau